Showing results (1441-1450 of 1,615) with videos related to

Sort By:
Pageof 162
World Journal of Urology|June 23, 2025
Impact of ureteroscopy on renal function in solitary kidneys: a systematic reviewCharles Jaouen, Olivier Traxer, Stefano Moretto, et al.
ESMO Open|April 17, 2024
Predicting early recurrence after resection of initially unresectable colorectal liver metastases: the role of baseline and pre-surgery clinical, radiological and molecular factors in a real-life multicentre experienceR Moretto, M M Germani, B Borelli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2011
Phase I study of decitabine in combination with vorinostat in patients with advanced solid tumors and non-Hodgkin's lymphomasAnastasios Stathis, Sebastien J Hotte, Eric X Chen, et al.
European Journal of Cancer (Oxford, England : 1990)|August 27, 2025
FOLFOXIRI/bevacizumab versus doublets/bevacizumab as initial therapy of unresectable liver-only, right-sided and/or RAS or BRAF mutated metastatic colorectal cancer: An individual patient data-based pooled analysis of randomized trialsCarlotta Antoniotti, Federica Marmorino, Daniele Rossini, et al.
Critical Reviews in Oncology/Hematology|July 19, 2015
Acute skin toxicity management in head and neck cancer patients treated with radiotherapy and chemotherapy or EGFR inhibitors: Literature review and consensusElvio G Russi, Francesco Moretto, Monica Rampino, et al.
Journal of Robotic Surgery|December 29, 2025
Extraperitoneal robot-assisted radical prostatectomy with the Hugo™ RAS system: 100 consecutive cases, 1-year follow-up and surgical learning curve evaluationMarcello Scarcia, Giovanni Battista Filomena, Marco Montesi, et al.
Antioxidants (Basel, Switzerland)|July 29, 2025
Guarana, Selenium, and L-Carnitine Supplementation Improves the Oxidative Profile but Fails to Reduce Tissue Damage in Rats with OsteoarthritisAline Zuanazzi Pasinato, José Eduardo Vargas, Julia Spanhol da Silva, et al.
The Oncologist|July 7, 2016
Location of Primary Tumor and Benefit From Anti-Epidermal Growth Factor Receptor Monoclonal Antibodies in Patients With RAS and BRAF Wild-Type Metastatic Colorectal CancerRoberto Moretto, Chiara Cremolini, Daniele Rossini, et al.
British Journal of Cancer|February 9, 2023
Trop-2 and Nectin-4 immunohistochemical expression in metastatic colorectal cancer: searching for the right population for drugs' developmentRoberto Moretto, Marco Maria Germani, Mirella Giordano, et al.
JCO Precision Oncology|October 5, 2023
Predictive Impact of <i>RNF43</i> Mutations in Patients With Proficient Mismatch Repair/Microsatellite Stable <i>BRAFV600E</i>-Mutated Metastatic Colorectal Cancer Treated With Target Therapy or ChemotherapyRoberto Moretto, Marco Maria Germani, Javier Ros, et al.
Pageof 162